Product Document Searching Made Easy by 2D Code! | TCI Chemistry News November 2025 | [TCIPracticalExample] The Z-Selective Horner-Wadsworth-Emmons Reaction... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 209216-23-9 | 產品號碼: E0899
Entecavir Monohydrate
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
補充產品訊息:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| 產品號碼 | E0899 |
純度/分析方法
|
>98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__1__2H__1__5N__5O__3·H__2O = 295.30 |
| 外觀與形狀(20°C) | Solid |
儲存條件
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器
|
200MG-Glass Bottle with Plastic Insert (閲覽圖片) |
| CAS RN | 209216-23-9 |
相關CAS RN
|
142217-69-4 |
| Reaxys-RN | 14632881 |
| PubChem Substance ID | 253660820 |
| Merck Index(14) | 3595 |
| MDL編號 | MFCD09754448 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | +34.0 to +38.0 deg(C=0.25, H2O)(calcd.on anh.substance) |
| Water | 4.0 to 9.0 % |
性質
| 熔點 | 259 °C(dec.) |
| 比旋光 [α]D | 36° (C=0.25,H2O) |
| Degree of solubility in water | 2.4 g/l |
| 溶解性(可溶於) | Dimethylformamide |
| 溶解性(微溶於) | Methanol |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H302 : Harmful if swallowed. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
運輸資料
| HS編碼* | 2933.99-000 |
Application
Cefdinir: A Third-Generation Cephalosporin More Active Against Gram-Positive Organisms
Entecavir (ETV or BMS-200475), a deoxyguanosine analog, is rapidly phosphorylated in vivo to the active intracellular 5'-triphosphate form that inhibits replication of hepatitis B virus (HBV) and shows reduced activity against other viruses, including HIV-1, influenza and herpes simplex viruses. Entecavir is a nucleoside reverse transcriptase inhibitor (NRTI). It inhibits reverse transcription in the viral replication process. (The product is for research purpose only.)
References
- BMS-200475, a novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro
- Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus
- Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro
- Potent efficacy of entecavir (BMS-200475) in a Duck model of hepatitis B virus replication
- Inhibition of hepatitis B virus polymerase by entecavir
- Entecavir: A review of its use in chronic hepatitis B
PubMed Literature
文檔
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)

